[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-361954-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-361954-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","artificial-intelligence-based-pathology-to-assist-prediction-of-neoadjuvant-therapy-responses-for-breast-cancer","Artificial Intelligence-Based Pathology to Assist Prediction of Neoadjuvant Therapy Responses for Breast Cancer","","Neoadjuvant therapy (NAT) is standard breast cancer care, yet patient responses differ markedly. Conventional histopathological and biomarker assessment is limited by inter-pathologist variability arising from complex tumor histology and heterogeneity. This review synthesizes research on artificial intelligence applied to image-based omics to improve precision and consistency. It summarizes models using morphological features, molecular markers, gene expression profiles, and multidimensional omics for predicting NAT response. The review concludes AI-based pathology is a decision-support tool with remaining challenges, especially in robust multi-omics prediction.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/artificial-intelligence-based-pathology-to-assist-prediction-of-neoadjuvant-therapy-responses-for-breast-cancer/361954/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/artificial-intelligence-based-pathology-to-assist-prediction-of-neoadjuvant-therapy-responses-for-breast-cancer/361954.png","ImageObject",300,407,{"name":42,"@type":43},"Aria","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is predicting neoadjuvant therapy (NAT) response difficult in breast cancer?","Question",{"text":63,"@type":64},"Patient responses vary significantly, and interpretation of histopathology and biomarkers is affected by inter-pathologist variability due to complex histology and tumor heterogeneity.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What kinds of features do AI models use to predict NAT response?",{"text":68,"@type":64},"The review focuses on diverse histopathological features, including morphological characteristics, molecular markers, gene expression profiles, and multidimensional omics data.",{"name":70,"@type":61,"acceptedAnswer":71},"What capabilities do AI-based pathology approaches provide for NAT prediction?",{"text":72,"@type":64},"AI can automatically recognize histopathological patterns and predict NAT efficacy, showing promise for patient stratification in precision oncology.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},361954,1790657900,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":109,"preview_page_count":33,"preview_urls":145},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","Cancer Medicine  \n|  REVIEW  OPEN ACCESS \u003Cbr>Artificial Intelligence-Based Pathology to Assist Prediction of Neoadjuvant Therapy Responses for Breast Cancer\u003Cbr>Juan Ji1  | Fanglei Duan1 | Qiong Liao1 | Hao Wang2 | Shiwei Liu2 | Yang Liu1 | Zongyao Huang1\u003Cbr>1Department of Pathology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China | 2Department of Breast, Sichuan Cancer Hospital & Institute,\u003Cbr>Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China Correspondence: Zongyao Huang ([huangzongyao@scszlyy.org.cn](huangzongyao@scszlyy.org.cn))\u003Cbr>Received: 31 January 2025 | Revised: 9 July 2025 | Accepted: 27 July 2025\u003Cbr>Funding: The authors received no specific funding for this work.\u003Cbr>Keywords: artificial intelligence | breast cancer | neoadjuvant therapy | pathology | prediction |  |\n| --- | --- |\n| ABSTRACT\u003Cbr>Background: Neoadjuvant therapy (NAT) is a standard breast cancer treatment, but patient response varies significantly. Predictive markers can guide treatment decisions, yet their interpretation suffers from inter-pathologist variability due to breast cancer's complex histology and heterogeneity. Artificial intelligence (AI) applied to image-based omics offers potential to enhance pathological interpretation precision and consistency.\u003Cbr>Methods: This review synthesizes existing literature on the application of AI in breast cancer pathology. We specifically focused on identifying and summarizing research that utilizes diverse histopathological features—including morphological characteristics, molecular markers, gene expression profiles, and multidimensional omics data—to predict NAT response in breast cancer patients. Results: AI demonstrates significant capabilities in automatically recognizing histopathological patterns and predicting NAT efficacy. It shows promise as a tool for patient stratification in precision oncology. Research utilizing various pathological feature types (morphological, molecular, genomic, multi-omics) for NAT response prediction is actively evolving. While AI models integrating multi-omics features show potential, challenges remain in robustly predicting NAT outcomes.\u003Cbr>Conclusion: AI-based pathology represents a prospective and powerful decision-support tool for predicting breast cancer NAT response. Despite existing challenges, particularly with complex multi-omics models, AI holds great potential to assist clinical oncologists in optimizing future cancer treatment management. |  |\n| 1 | Introduction | histopathological and biomarker assessment, have limitations in accuracy and efficiency [3] . |\n| Breast cancer is the most common malignant tumor in women |  |\n| worldwide [1] . Neoadjuvant therapy (NAT) can improve | Emerging digital pathology technologies offer a solution by en- |\n| treatment outcomes, but patient responses vary greatly [2] . | abling faster, more objective evaluation of tumor characteristics |\n| Conventional methods for evaluating NAT response, such as | and treatment response. Digital pathology integrates pathology |\n| Juan Ji and Fanglei Duan contributed equally to this work as co-first authors. |  |\n| This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.\u003Cbr>© 2025 The Author(s). Cancer Medicine published by John Wiley & Sons Ltd. |  |\n\nCancer Medicine, 2025; 14:e71132 1 of 16  \n[https://doi.org/10.1002/cam4.71132](https://doi.org/10.1002/cam4.71132)  \nimages, including morphology and molecular data, for computational analysis across diseases. Studies show digital histology achieves consistency with traditional glass slides and sometimes surpasses diagnostic performance [4, 5] .  \nDigital pathology emerged in t","cbCaifcwL1Gkjurk","https://ap.wps.com/l/cbCaifcwL1Gkjurk","pdf",1249649,16,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n# Digital pathology and AI methods\n## Machine learning\n## Deep learning and CNNs\n## End-to-end AI approaches","[{\"question\":\"Why is predicting neoadjuvant therapy (NAT) response difficult in breast cancer?\",\"answer\":\"Patient responses vary significantly, and interpretation of histopathology and biomarkers is affected by inter-pathologist variability due to complex histology and tumor heterogeneity.\"},{\"question\":\"What kinds of features do AI models use to predict NAT response?\",\"answer\":\"The review focuses on diverse histopathological features, including morphological characteristics, molecular markers, gene expression profiles, and multidimensional omics data.\"},{\"question\":\"What capabilities do AI-based pathology approaches provide for NAT prediction?\",\"answer\":\"AI can automatically recognize histopathological patterns and predict NAT efficacy, showing promise for patient stratification in precision oncology.\"}]","Artificial Intelligence-Based Pathology to Assist Prediction of Neoadjuvant Therapy Responses for Breast Cancer | PDF",1790146119,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a69fa7d891cedae935e0a41a1f388cf3.webp",983,1291,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c72c02bd87a583b2c00bc662880e8f96.webp",982,1290,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ed251b16f179cff01d4093dcb34f0865.webp",981,1289,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/419f026ecc1d23fb3b13ffaf665bcdaf.webp",980,1287]